OMNY Health, a leading healthcare ecosystem known for facilitating compliant cross-industry data sharing, recently announced the first expansion of its c-suite since 2021. Ivy Weng, MD, former Group Vice President of Life Sciences at Komodo Health, will join OMNY Health as its first Chief Commercial Officer following its most significant growth milestone yet: one billion patient encounters, impacting the care outcomes of millions of patients.
Weng will oversee OMNY Health’s commercial operations as it scales, drives revenue growth, and elevates its market presence in life sciences, AI, medical devices, and clinical research organizations. Weng’s extensive background in the life sciences sector includes leading enterprise multi-year software sale deals exceeding $50 million with the top 20 pharmaceutical companies. Her experience across areas such as commercial analytics, medical affairs, market access, RWE/HEOR, clinical development, and R&D will be instrumental in advancing OMNY Health’s development and implementation of commercial strategy.
OMNY Health’s work with AI and life sciences partners, such as QuantHealth and ArisGlobal expedites drug development through simulated clinical trials and utilizes real-world evidence to predict clinical trial outcomes, drug efficacy, and patient responses. And OMNY Health’s data also addresses disparities in pharma by closing significant demographic information gaps in drug discovery and development.
This management deal follows the company’s GLP-1 Data Network, which supplies life sciences and health system partners, as well as its AI-driven health tech partners, with additional knowledge of GLP-1 use, related social determinants of health (SDOH), and patient demographics to better inform generative AI tools, researchers, and clinicians.
KEY QUOTES:
“I’m excited to join OMNY Health and continue driving our mission of enhancing healthcare data connectivity and accessibility. OMNY’s platform uniquely connects providers with life sciences companies, creating a virtuous cycle that directly benefits both clinicians and patient outcomes. OMNY is building the richest tapestry of representative patient encounters—and we’re just getting started.”
- Ivy Weng, MD, former Group Vice President of Life Sciences at Komodo Health
“We have merely scratched the surface of OMNY Health’s impact with our milestone of one billion patient encounters. Although we’ve seen tremendous growth since 2017, there remains a vast amount of work ahead in democratizing access to data and empowering life sciences, health systems, AI companies, and more to drive healthcare innovation. Appointing Ivy Weng to lead our commercial division was a clear decision – her leadership will be instrumental in advancing OMNY Health’s mission to enable deeper clinical research and impact the lives of millions more as we continue to expand.”
- Mitesh Rao, MD, Founder and CEO of OMNY Health
